With high dropout rates threatening the viability of 2 postmarket safety studies of silicone breast implants, the US Food and Drug Administration (FDA) in August convened an advisory committee hearing to determine the best way to assess these devices in the absence of results from these studies. The agency required manufacturers to conduct such research as concerns about the safety of these devices emerged.
The meeting was closely watched by consumer advocates and clinical experts, who say it highlights the ongoing difficulties the agency has had in ensuring that device makers follow through on required postmarket studies of medical devices. Even though such research is frequently required by the agency as a condition of approval, companies often fail to follow through. Critics argue that tougher sanctions from the agency or greater collaboration among government agencies to ensure collection of the necessary data may help resolve this problem.
Graphic Jump Location
Although rupture and other common adverse events associated with silicone breast implants have been well documented, there is a dearth of information about rare or longer-term problems associated with the devices.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.